Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, October 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 353 articles:
HTML format


 

Single Articles

  1. ASLAN B, Onal O
    Factors influencing the decision to undergo cervical cancer screening tests (Pap Smear and HPV-DNA testing) in women aged 30-65: The role of HPV knowledge, cancer screening perception, health anxiety, and behaviors for protection against sexually tran
    J Health Psychol. 2025 Oct 3:13591053251376855. doi: 10.1177/13591053251376855.
    PubMed    
    Abstract available

  2. LEE J, Lim H, Baek IW, Chung MK, et al
    Cervical cancer screening rates in Korean women of childbearing age with systemic lupus erythematosus.
    Lupus. 2025 Oct 3:9612033251386086. doi: 10.1177/09612033251386086.
    PubMed    
    Abstract available

  3. RIVERO-MENDOZA D, Gjoka K, Singh L, Adkins L, et al
    Health System Strategies to Improve the Uptake of Cervical Cancer Screening in Sub-Saharan Africa: A Scoping Systematic Review.
    Health Promot Pract. 2025 Oct 3:15248399251370668.
    PubMed    
    Abstract available

  4. MOUKAM AMD, Salah N, Tankeu Happi GW, Metchehe LDD, et al
    Acceptability of home-based HPV self-sampling for cervical cancer screening among users and providers in the West region of Cameroon: a cross-sectional study.
    BMC Health Serv Res. 2025;25:1303.
    PubMed    
    Abstract available

  5. FENG S, Gunawan R, Passey C, Voellinger J, et al
    Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin.
    J Pharmacokinet Pharmacodyn. 2025;52:55.
    PubMed    
    Abstract available

  6. JAYAKUMAR B, Ngua Roca A, Teklemichael L, Ondo Oyono M, et al
    Lessons Learned From 7 Years of Implementing Cervical Cancer Screening and Treatment in Equatorial Guinea.
    JCO Glob Oncol. 2025;11:e2400658.
    PubMed    
    Abstract available

  7. NGUYEN VT, Arockiam S, Kumar P, Eger J, et al
    Diagnostic Translational Considerations for Global Health Settings: Portable Detection of Human Papillomavirus for Cervical Cancer Screening in India.
    JCO Glob Oncol. 2025;11:e2500117.
    PubMed    
    Abstract available

  8. ASEMPAH E, Ikpebe E, Wyndham-West M, Wiktorowicz ME, et al
    Challenges and Opportunities for Cervical Cancer Prevention Through HPV Vaccination in Ghana: A Public Health Policy Analysis.
    Cancer Control. 2025;32:10732748251383280.
    PubMed    
    Abstract available

  9. KAPLAN C, Crane L, Collins A, Parker RL, et al
    At-home self-collection device offers an effective and preferred method to engage high BMI women in cervical cancer screening: method comparison study.
    Arch Gynecol Obstet. 2025 Oct 3. doi: 10.1007/s00404-025-08189.
    PubMed    
    Abstract available

  10. WANG K, Sun J, Zhang H, Li L, et al
    Research on the Effect of NK Cells Based on Functionalized Magnetic Beads on Cervical Cancer Mice.
    ACS Appl Bio Mater. 2025 Oct 3. doi: 10.1021/acsabm.5c00811.
    PubMed    
    Abstract available

  11. ZHANG N
    Early detection and management strategies for isolated splenic metastasis in cervical cancer: a case report.
    Front Oncol. 2025;15:1639109.
    PubMed    
    Abstract available

  12. SUTRISNO S, Marlina D, Dewi Poernomo MAP, Utomo A, et al
    Elevated Body Mass Index as a Predictor of Cervical Cancer and Precancerous Lesions.
    Med Sci Monit. 2025;31:e947820.
    PubMed    
    Abstract available

  13. BARMON D, Nath A, Aparajita, Sharma JD, et al
    Advocacy to action for cervical cancer elimination in the state of Assam: a narrative review of the government policies and the latest report of NCDIR survey.
    BMC Health Serv Res. 2025;25:1291.
    PubMed    
    Abstract available

  14. QUAN C, Jiang P, Gao G, Wang Z, et al
    Mesoporous silica-coated gold nanorod grafted with cisplatin prodrug on the surface enhances radiotherapy for cervical cancer via triple-strategy approach.
    Colloids Surf B Biointerfaces. 2025;257:115160.
    PubMed    
    Abstract available

  15. MARINO JM, Silva CM, Silva UAOD, Wanderley LC, et al
    Facilitators and barriers to the Papanicolaou test on women in countryside of Amazonas.
    Rev Gaucha Enferm. 2025;46.
    PubMed    
    Abstract available

  16. THAKER PH, Lu H, Zhang YJ, Trapali M, et al
    Treatment preferences of patients with recurrent or metastatic cervical cancer: a discrete choice experiment in the US.
    Gynecol Oncol Rep. 2025;61:101947.
    PubMed    
    Abstract available

  17. SU Q, Tian X, Li F, Yu X, et al
    Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer.
    Front Immunol. 2025;16:1612623.
    PubMed    
    Abstract available

  18. SHARMA M, Chourasia N, Priyanka P, Sarkar DP, et al
    Functional characterization of dysregulated LncRNAs in BRCA and CESC highlights their role in cancer prognosis.
    Sci Rep. 2025;15:34265.
    PubMed    
    Abstract available

  19. MAQBOOL T, Hadi F, Naz S, Inamullah, et al
    Pulegone induced apoptotic and anti-proliferative potential in cervical cancer via P53, BAX and BCL2.
    Sci Rep. 2025;15:34217.
    PubMed    
    Abstract available

  20. MEENAN RT, Lacey C, Buist DSM, Tiro JA, et al
    Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening.
    JAMA Netw Open. 2025;8:e2534960.
    PubMed    
    Abstract available

  21. DUHORANENAYO D, Nyiraneza SE, Rugengamanzi E, Sungura R, et al
    Treatment response after chemoradiation with an external beam radiation therapy boost in cervical cancer patients in Rwanda.
    Oncologist. 2025 Oct 1:oyaf328. doi: 10.1093.
    PubMed    
    Abstract available

  22. HU S, Lu Y, Pandey P, Mujtaba MA, et al
    Oroxylin A exerts antiproliferative effects through downregulation of E6 and E7 oncogenes in cervical cancer HeLa cells.
    Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct 1. doi: 10.1007/s00210-025-04601.
    PubMed    
    Abstract available

  23. SATOH M, Sato N, Sekino M
    Behavioral economics, lifestyle, and health-related factors associated with participation in breast and cervical cancer screenings: A cross-sectional analysis of Japanese women.
    Prev Med Rep. 2025;59:103249.
    PubMed    
    Abstract available

  24. CHEN J, Zhang M, Gong Y, Gu Z, et al
    The Role of the Vaginal Microbiome in Immune Modulation in Cervical Cancer: Composition, Molecular Mechanisms, and Therapeutic Potential.
    Clin Med Insights Oncol. 2025;19:11795549251380470.
    PubMed    
    Abstract available

  25. TAKAHASHI T, Kobayashi Y, Sakurai R, Matsuoka K, et al
    A Systematic Review of the Application of Artificial Intelligence in Colposcopy: Diagnostic Accuracy for Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251374908.
    PubMed    
    Abstract available

  26. BAN R, Zeng J, Hao J
    Dosimetric study on the effect of minimum distance between optimization structures and planning target volume on small intestine dose in cervical cancer VMAT plans.
    Medicine (Baltimore). 2025;104:e44715.
    PubMed    
    Abstract available

  27. YAN Y, Zhang L, Yuan S, Zhang T, et al
    Association between the oxidative balance score and gynecologic cancers from the National Health and Nutrition Examination Survey: An observational study.
    Medicine (Baltimore). 2025;104:e44782.
    PubMed    
    Abstract available

  28. CHOUDHARY S, Pandey A, Singh A, Mourya A, et al
    Comparison of intravaginal and interstitial brachytherapy in cervical cancer after inadvertent hysterectomy: a retrospective study.
    Sci Rep. 2025;15:33784.
    PubMed    
    Abstract available

  29. LIU C, Ding L, Chen S, Liu L, et al
    Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG.
    Mol Pharm. 2025 Sep 30. doi: 10.1021/acs.molpharmaceut.5c00765.
    PubMed    
    Abstract available

  30. HONORE I, Bargisen M, Knudsen AS, Lyngso J, et al
    [Postcoital bleeding in premenopausal women].
    Ugeskr Laeger. 2025;187:V03250162.
    PubMed    
    Abstract available

  31. YAO S, Chen S, Wan S, Wang A, et al
    LAG3 as a Tumor Suppressor and Immune Regulator in Cervical Cancer: From Functional Validation to Therapeutic Strategy.
    Cancer Med. 2025;14:e71278.
    PubMed    
    Abstract available

  32. SONG L, Qin K, Bai S, Wu Q, et al
    Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis.
    PeerJ. 2025;13:e20069.
    PubMed    
    Abstract available

  33. HE XY, Huang Y, Qiao CP, Ma J, et al
    Fertility anxiety partially mediates depression and recurrence fear in reproductive-age cervical cancer patients: A cross-sectional study.
    World J Clin Oncol. 2025;16:110031.
    PubMed    
    Abstract available

  34. DONG M, Xie J, Zhao X, Zhao F, et al
    Impact of government-organized screening programs on the economic burden of cervical cancer across five disease courses: a multistage regression and mediation analysis.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0418.
    PubMed    
    Abstract available

  35. JIA X, Gao C, Da X, Shi J, et al
    Evaluation of an intelligent digital platform for population management in cervical cancer screening.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0419.
    PubMed    
    Abstract available

  36. BASU P
    Progress toward cervical cancer elimination: global disparities and China's contributions.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0428.
    PubMed    


  37. WANG M, Xu J, Xu S, Wu Y, et al
    The primary surgery improved the survival of FIGO stage IIIC1 cervical cancer with T1b-T2a tumors.
    BMC Womens Health. 2025;25:454.
    PubMed    
    Abstract available

  38. FENG T, Zhang W, Zhao T, Zhou S, et al
    Comparative analysis of preoperative and postoperative HPV infection dynamics in patients with cervical intraepithelial neoplasia and cervical cancer: implications for screening and management.
    BMC Infect Dis. 2025;25:1195.
    PubMed    
    Abstract available

  39. FENG S, Zhao M, Zhang D, Zhang Y, et al
    TUFT1 regulates cancer progression by suppressing centrosome amplification and mitotic spindle multipolarity.
    Cell Death Dis. 2025;16:673.
    PubMed    
    Abstract available

  40. KUIPERS SC, van Tuyll van Serooskerken M, Lathouwers D, Corbeau A, et al
    Predicting lymphocyte dose and surviving fraction for VMAT and IMPT treatments with a dynamic lymphocyte flow model for locally advanced cervical cancer.
    Phys Med Biol. 2025 Sep 29. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  41. LE THI P, Nguyen HT, Quoc Nguyen V, Tran Nguyen H, et al
    Enhanced Cytotoxicity of Cisplatin-Loaded Brij S100-Alginate-Taurine Nanogels Against HeLa Cervical Cancer Cells.
    Nanotechnology. 2025 Sep 29. doi: 10.1088/1361-6528.
    PubMed    
    Abstract available

  42. SOLER M, Alfaro K, Rauda JC, Torres E, et al
    Adoption and Implementation of Affordable Cancer Technologies in El Salvador: Identifying Implementation Strategies for Successful Cervical Cancer Prevention in Resource-Limited Settings.
    JCO Glob Oncol. 2025;11:e2500065.
    PubMed    
    Abstract available

  43. AZIM MR, Wong EYT, Rahman MM, Islam MS, et al
    Knowledge, Attitudes, and Health-Seeking Behavior for Cervical, Breast, and Oral Cancers Among Women in Jashore, Bangladesh: A Cross-Sectional Study.
    JCO Glob Oncol. 2025;11:e2500304.
    PubMed    
    Abstract available

  44. LI J, Wang Y, Pei J, Wang M, et al
    Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors.
    Discov Oncol. 2025;16:1756.
    PubMed    
    Abstract available

  45. ZACAPALA-GOMEZ AE, Hernandez-Galicia G, Torres-Rojas FI, Banos-Hernandez CJ, et al
    Let-7c/RUNX1 Axis Promotes Cervical Cancer: A Bioinformatic Analysis.
    Curr Issues Mol Biol. 2025;47:757.
    PubMed    
    Abstract available

  46. VARESANO S, Ciccarese G, Parente P, Paudice M, et al
    Integrating Molecular Diagnostics into Cervical Cancer Screening: A Workflow Using FFPE Tissue Samples.
    Curr Issues Mol Biol. 2025;47:679.
    PubMed    
    Abstract available

  47. QIU Z, Yu X, Wang T
    Differential cardiovascular outcomes of radiotherapy in rectal, breast, and cervical cancer: insights from a SEER data analysis.
    Radiat Prot Dosimetry. 2025 Sep 29:ncaf111. doi: 10.1093.
    PubMed    
    Abstract available

  48. LIU B, Bao Y, Ma J, Wang X, et al
    Clinical Efficacy of Hydrogen Therapy on Acute Radiation Enteritis and Inflammatory Response in Patients with Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
    Adv Radiat Oncol. 2025;10:101879.
    PubMed    
    Abstract available

  49. MA Y, Lai X, Fang H
    Global, regional, and national disease burden and economic costs of cervical cancer (1991-2021): a multidimensional data synthesis analysis.
    Front Public Health. 2025;13:1633975.
    PubMed    
    Abstract available

  50. RAI H, Verma D, Meena R, Uniya U, et al
    Cervical Cancer Screening in HIV-Positive Women by Conventional Exfoliative Cytology and Liquid-Based Cytology.
    Cureus. 2025;17:e91118.
    PubMed    
    Abstract available

  51. MLAMBO A, Su S, Dhlamini Q, Zhang Y, et al
    Patterns of immune cell infiltration and oxidative stress in cervical cancer.
    Oncol Rev. 2025;19:1570071.
    PubMed    
    Abstract available

  52. LIU Y, Zhang X, Xin W, Ding Y, et al
    A long-term retrospective analysis of oncologic and fertility outcomes in cervical cancer patients undergoing radical trachelectomy.
    Front Oncol. 2025;15:1591923.
    PubMed    
    Abstract available

  53. LI B, Chen L, Sun C, Wang J, et al
    Leveraging deep learning for early detection of cervical cancer and dysplasia in China using U-NET++ and RepVGG networks.
    Front Oncol. 2025;15:1624111.
    PubMed    
    Abstract available

  54. SHI P, Zhang W, Yao Q, Yuan Z, et al
    Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer.
    Front Oncol. 2025;15:1697346.
    PubMed    
    Abstract available

  55. LUO S, Yin Y, Qiu L, Wang H, et al
    [Function evaluation of urinary, bowel, pelvic floor functions of patients after nerve-sparing radical hysterectomy based on CC-PRO137 scale].
    Zhonghua Yi Xue Za Zhi. 2025;105:3188-3194.
    PubMed    
    Abstract available

  56. BAVISHI L, Butani SB, Patel SS
    Small Interfering RNA (siRNA) Based Therapies for Cancer Treatment: A Special Focus on Cervical Cancer.
    Eur J Pharmacol. 2025 Sep 26:178198. doi: 10.1016/j.ejphar.2025.178198.
    PubMed    
    Abstract available

  57. HUANG Y, Lin W, Chen X, Zheng X, et al
    Analyzing and forecasting global cervical cancer burden based on WHO's elimination strategy: insights and projections from a 1990-2021 global burden of disease (GBD) study covering 204 countries and territories.
    J Adv Res. 2025 Sep 25:S2090-1232(25)00742-8. doi: 10.1016/j.jare.2025.
    PubMed    
    Abstract available

  58. MOSS JL, Bernacchi VE, Entenman J, Costigan H, et al
    Follow-Up After Receiving Abnormal Results From Self-Sampled Colorectal and Cervical Cancer Screening Tests Among Underserved Patients.
    Cancer Med. 2025;14:e71283.
    PubMed    
    Abstract available

  59. QIAO Y
    Eliminating cervical cancer: a global health imperative for women.
    Cancer Biol Med. 2025 Sep 26:j.issn.2095-3941.2025.0529.
    PubMed    


  60. CHETTA M, Rosati A, Bukvic N
    HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks.
    Viruses. 2025;17:1166.
    PubMed    
    Abstract available

  61. MENG X, Yang B, Yin H, Chen J, et al
    Global Burden and Incidence Trends in Cancers Associated with Human Papillomavirus Infection: A Population-Based Systematic Study.
    Pathogens. 2025;14:880.
    PubMed    
    Abstract available

  62. KAFASI A, Pitiriga VC, Spanakis N, Vlachos N, et al
    Evaluation of the PreTect HPV-Proofer E6/E7 mRNA Assay for the Detection of Precancerous Cervical Lesions in the Greek Female Population.
    Pathogens. 2025;14:853.
    PubMed    
    Abstract available

  63. ALABDULLATIF A, Almofty S, Tanimu G, Dafalla H, et al
    Tribulus terrestris-Mediated ZnO/Ag-Halloysite Nanohybrids for Targeted Cisplatin and Carboplatin Delivery in Cervical Cancer Treatment.
    Pharmaceuticals (Basel). 2025;18:1349.
    PubMed    
    Abstract available

  64. YORDANOV A, Tsoneva E, Hasan I, Kostov S, et al
    Sentinel Lymph Node Dissection-Novelty, Trend, or a Paradigm Shift in Surgical Decision-Making for Early Cervical Cancer?
    Medicina (Kaunas). 2025;61:1660.
    PubMed    
    Abstract available

  65. MARTINS TR, Levi JE
    Molecular Screening for Cervical Cancer.
    Genes (Basel). 2025;16:1041.
    PubMed    
    Abstract available

  66. LI J, Li S
    From Viral Infection to Genome Reshaping: The Triggering Role of HPV Integration in Cervical Cancer.
    Int J Mol Sci. 2025;26:9214.
    PubMed    
    Abstract available

  67. LEE KJ, Kim G, Seo B, Jeong SY, et al
    A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines.
    Int J Mol Sci. 2025;26:8941.
    PubMed    
    Abstract available

  68. HABIB N, Idoubba S, Futcher F, Pieri E, et al
    Cervical Cancer Treatment and Fertility: What We Know and What We Do.
    Cancers (Basel). 2025;17:3057.
    PubMed    
    Abstract available

  69. PARULEKAR M, Kim MK, Noh JJ, Suh DH, et al
    Clinicopathological Factors Affecting Prognosis in Patients with Advanced Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
    Cancers (Basel). 2025;17:3042.
    PubMed    
    Abstract available

  70. GUITIAN M, Reina G, Carlos S
    The Role of Nutrition in HPV Infection and Cervical Cancer Development: A Review of Protective Dietary Factors.
    Cancers (Basel). 2025;17:3020.
    PubMed    
    Abstract available

  71. RESTIVO V, Graci D, Immordino A, Mancuso DG, et al
    Cervical Cancer Screening in Refugee and Migrant Populations: Results of Systematic Review and Meta-Analysis in Cross-Sectional and Cohort Studies.
    Cancers (Basel). 2025;17:2966.
    PubMed    
    Abstract available

  72. KOWALKOWSKA ME, Kaminska K, Wojtysiak J, Koper K, et al
    Tumor Mutational Burden in Cervical Cancer as Potential Marker for Immunotherapy Responders.
    Cancers (Basel). 2025;17:2963.
    PubMed    
    Abstract available

  73. NCANE Z, Gonah L, Estrada GAP, Faleni M, et al
    Knowledge, Attitudes, and Practices of Healthcare Workers on Cervical Cancer Screening in Rural Healthcare Facilities of the Eastern Cape.
    Healthcare (Basel). 2025;13:2316.
    PubMed    
    Abstract available

  74. YORDANOV A, Damyanova P, Vasileva-Slaveva M, Karakadieva K, et al
    Clinical Significance of Tumor Infiltrating T-Helper and Regulatory Cells in Bulgarian Cervical Cancer Patients.
    Biomedicines. 2025;13:2206.
    PubMed    
    Abstract available

  75. MASCARENHAS M, Martins M, Barroso L, Spindler L, et al
    Automated detection and classification of cervical and anal squamous cancer precursors using deep learning and multidevice colposcopy.
    Sci Rep. 2025;15:33068.
    PubMed    
    Abstract available

  76. GNANAGURUSAMY J, Sabanayagam R, Krishnamoorthy S, Balasubramanian V, et al
    EGCG remodels the TGF-beta cervical cancer micro-environment towards immune responsiveness.
    Cell Immunol. 2025;418:105027.
    PubMed    
    Abstract available

  77. ANDERER S
    Anal Cancer Risk Rises With Age and Time Among Cervical Cancer Survivors.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13888.
    PubMed    


  78. GUPTA RD, Saha S, Rahman MA, Addo PNO, et al
    Factors influencing breast and cervical cancer screening among ever-married women aged 15-49 in Jordan: an analysis of the 2023 Jordan population and family health survey.
    J Egypt Natl Canc Inst. 2025;37:65.
    PubMed    
    Abstract available

  79. SANTIAGO-RODRIGUEZ EJ, Ramos TS, Ramos-Cartagena JM, Torres-Cintron CR, et al
    Effects of Hurricanes and the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Diagnosis in Puerto Rico.
    O G Open. 2024;1:36.
    PubMed    
    Abstract available

  80. GAO C, Zhou Q, Liu L, Liu H, et al
    Stratification by Mutational Landscape Reveals Differential Immune Infiltration and Predicts the Recurrence and Clinical Outcome of Cervical Cancer.
    Phenomics. 2025;5:384-403.
    PubMed    
    Abstract available

  81. ALIMENA S, Lykken JM, Tiro JA, Chubak J, et al
    Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health Record.
    O G Open. 2024;1:32.
    PubMed    
    Abstract available

  82. LIU H, Zhang Z, Guo X, Wang T, et al
    The Effect of Bladder and Rectum Volume Changes on Exposed Organ Volume During Intensity-Modulated Radiotherapy for Cervical Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251377910.
    PubMed    
    Abstract available


  83. Correction to "Catastrophic Venous and Arterial Thrombosis in a Young Female With Cervical Cancer".
    EJHaem. 2025;6:e70149.
    PubMed    
    Abstract available

  84. CHEN S, Li T, Wang Y, Dai Y, et al
    The Impact of Specific Sexually Transmitted Pathogens on Cervix: A Prospective Study Based on Cervical Cancer Screening Cohort.
    J Med Virol. 2025;97:e70616.
    PubMed    
    Abstract available

  85. MABUCHI S, Komura N, Nakamura H, Maeda M, et al
    The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations.
    J Gynecol Oncol. 2025 Sep 15. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  86. JIN XH, Liu XM, Huang HY
    The mediating role of medical coping modes between anxiety and fear of progression in patients with cervical intraepithelial neoplasia grade 3: a cross-sectional survey.
    BMC Psychol. 2025;13:1019.
    PubMed    
    Abstract available

  87. SALEHI AM, Shahbazi F, Garavand R, Kamkari S, et al
    Global socioeconomic inequalities in breast, cervical, ovarian, and uterine cancers incidence, mortality, disability-adjusted life year's rates: a relative concentration index analysis.
    BMC Womens Health. 2025;25:433.
    PubMed    
    Abstract available

  88. SYDING LA, Plackova K, Pavelkova L, Aquino-Perez C, et al
    High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer.
    J Immunother Cancer. 2025;13:e012613.
    PubMed    
    Abstract available

  89. TAL S, Vowels JA, Gonzalez D, Polychronopoulou E, et al
    Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening: Insights from a Diverse Population-Based Retrospective Study.
    J Mol Diagn. 2025 Sep 23:S1525-1578(25)00218.
    PubMed    
    Abstract available

  90. CHEN W, Liu C, Li S, Xie X, et al
    ZC3H18 regulates alternative splicing and related genes in cervical cancer.
    Front Genet. 2025;16:1621238.
    PubMed    
    Abstract available

  91. ZHANG L, Zhang Q, Pang B, Tan Z, et al
    Epidemiological characteristics and risk factors of high-risk HPV infection, cervical cancer, and precancerous lesions among women in Southwestern China.
    Front Oncol. 2025;15:1645748.
    PubMed    
    Abstract available

  92. LI W, Wang X, Wu M, Tan X, et al
    Quality of life in cervical cancer survivors after nerve-sparing radical hysterectomy, conventional radical hysterectomy or concurrent chemoradiotherapy.
    Front Oncol. 2025;15:1654730.
    PubMed    
    Abstract available

  93. VASIC J, Prvulovic Bunovic N, Saroskovic M, Vukovic J, et al
    The apparent diffusion coefficient as a biomarker in the diagnosis of cervical cancer and the assessment of therapeutic response to chemoradiation therapy.
    Front Oncol. 2025;15:1610090.
    PubMed    
    Abstract available

  94. KUBURA D, Sampson S, Erekosima G, Dauda M, et al
    Stakeholders' perspectives on lessons learnt from HPV mass vaccination in Nigeria.
    BMC Public Health. 2025;25:3062.
    PubMed    
    Abstract available

  95. ZIDI S, Almawi WY, Abassi S, Khadraoui N, et al
    Genital mycoplasma infections: a hidden factor in cervical cancer progression? A systematic review and meta-analysis.
    BMC Infect Dis. 2025;25:1120.
    PubMed    
    Abstract available

  96. QIAN H, Tang M, Wu T, Sun Z, et al
    The Role of Replication Stress-Related Genes in Cervical Cancer Radiotherapy Resistance: A Bioinformatic and Experimental Validation.
    Lab Invest. 2025 Sep 22:104244. doi: 10.1016/j.labinv.2025.104244.
    PubMed    
    Abstract available

  97. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa.
    Vaccine. 2025;64:127770.
    PubMed    
    Abstract available

  98. TWABI HH, Sibande W, Mhango O, Msosa TC, et al
    Acceptability of self-sampling for high-risk HPV DNA testing for primary cervical cancer screening among women in Thyolo, Malawi: A qualitative study.
    PLOS Glob Public Health. 2025;5:e0004763.
    PubMed    
    Abstract available

  99. KIM M, Lee M, Kang J, Lee SJ, et al
    HPV ctDNA as a Biomarker for Monitoring Disease Progression in HPV16/18-Associated Cervical Cancer.
    Pathobiology. 2025 Sep 24:1-15. doi: 10.1159/000548452.
    PubMed    
    Abstract available

  100. STOLNICU S, Talia KL, Banet N, McCluggage WG, et al
    Lymphovascular Space Invasion in Cervical Cancer: A Review of Clinical Significance and Pathologic Issues.
    Int J Gynecol Pathol. 2025 Sep 3. doi: 10.1097/PGP.0000000000001135.
    PubMed    
    Abstract available

  101. LEE GH, Kim S, Kim SH, Lee ES, et al
    Transcription cascade reaction-driven isothermal amplification for ultrasensitive detection of high-risk human papillomavirus.
    Biosens Bioelectron. 2025;290:117984.
    PubMed    
    Abstract available

  102. WIJENAYAKE N, Ladino D, Patterson K, Rosim M, et al
    Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.
    J Med Econ. 2025;28:1651-1668.
    PubMed    
    Abstract available

  103. SUN W, Angelova A, Han X, Wang X, et al
    Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells.
    J Med Chem. 2025;68:18857-18868.
    PubMed    
    Abstract available

  104. CHEN Q, Wang H, Zhang H, Zhu Z, et al
    EdgeNeXt-SEDP for cervical adenocarcinoma HPV-associated and non-HPV-associated diagnosis and decision support.
    Life Sci. 2025;380:123931.
    PubMed    
    Abstract available

  105. BROOKS RT, Hulshizer CA, Hanson AC, Davis JM 3rd, et al
    Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0190. doi: 10.3899/jrheum.2025-0190.
    PubMed    
    Abstract available

  106. SMITH DG, Dantes EM, Beyl R, de Koter YXA, et al
    Perceived Risk and HPV Vaccination Awareness Among Women in Rural and Underserved Communities in the State of Louisiana.
    J Community Health. 2025;50:826-832.
    PubMed    
    Abstract available

  107. NAKAMURA K, Masuda K, Seki T, Kitago M, et al
    Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC).
    Keio J Med. 2025;74:158-161.
    PubMed    
    Abstract available

  108. TAO YC, Guo LC, Guo X, Huang RP, et al
    [Expression of keratin 1/sialyl-Tn antigen in primary and metastatic cervical squamous cell carcinomas].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1069-1074.
    PubMed    
    Abstract available

  109. WANG S, Yang X, Gao Z, Zhao M, et al
    The risk of Radiation-Associated second cancer in patients with cervical cancer following radiotherapy from 1975-2019.
    Oncologist. 2025 Oct 10:oyaf334. doi: 10.1093.
    PubMed    
    Abstract available

  110. MOUSAVINEJAD SN, Lachouri R, Ferdosi F, Khatami SH, et al
    Cervical cancer diagnostics: non-coding RNAs and biosensors to AI-derived methods.
    Clin Chim Acta. 2025 Oct 8:120641. doi: 10.1016/j.cca.2025.120641.
    PubMed    
    Abstract available

  111. AHMED A, Karsany M, Abdelwadoud M, Ali M, et al
    MOLECULAR DETECTION OF HIGH RISK HUMAN PAPILLOMA VIRUS SUBTYPES IN CERVICAL SMEARS AMONG SUDANESE WOMEN.
    Georgian Med News. 2025;.
    PubMed    
    Abstract available

  112. KURIATA N, Mazur KZ, Saemundarson MM, Urosevic Z, et al
    A Novel NGS-Based Algorithm for Precise HPV Genotyping and Co-infection Detection in QCMD Samples and FFPE Tissues.
    Curr Protoc. 2025;5:e70231.
    PubMed    
    Abstract available

  113. NAMOOS A, Abosamak N, Sheppard V
    A Pilot Study: Adaptation Phase of the PROMIS Women Education Program-Promoting Cervical Cancer Prevention Methods Among Muslim Women in Virginia.
    Cancer Med. 2025;14:e71296.
    PubMed    
    Abstract available

  114. TURUNEN IJ, Kalliala I, Pankakoski M, Partanen VM, et al
    High risk human papillomavirus versus cytological screening over two rounds in Finnish screening programme for cervical cancer: population based cohort study.
    BMJ Med. 2025;4:e001435.
    PubMed    
    Abstract available

  115. CIZICENO M, Bertolazzi A, Quaglia V
    Examining cervical cancer screening adherence: how does healthism influence participation?
    BMC Public Health. 2025;25:3420.
    PubMed    


  116. LO SHS, Chau JPC, Choi KC, Butt L, et al
    Effects of an educational health promotion intervention to improve human papillomavirus vaccination acceptance and uptake among adolescent girls: a cluster randomized controlled trial.
    BMC Public Health. 2025;25:3419.
    PubMed    
    Abstract available

  117. CAI W, Wang Y, Yan X, Zhou P, et al
    Successful use of ovarian vein as a ureteral substitute for long-segment ureteral stricture post-pelvic radiotherapy: a case report.
    BMC Surg. 2025;25:460.
    PubMed    
    Abstract available

  118. TIRO JA, Metcalfe S, Muthukrishnan M, Jose A, et al
    Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners.
    Patient Educ Couns. 2025;142:109374.
    PubMed    
    Abstract available

  119. EKATERINA K, Andreas Martin K, Irakli K, Elene K, et al
    Artificial intelligence generated visual communication improves comprehension and adherence in cervical cancer screening: a randomized controlled study.
    Int J Med Inform. 2025;205:106134.
    PubMed    
    Abstract available

  120. ZHANG X, Dong X, Starr D, Bai X, et al
    Assessment of the efficiency and accuracy of an artificial intelligence assistive system in the diagnosis of Pap cervical atypical glandular cell cytology.
    Cancer Cytopathol. 2025;133:e70056.
    PubMed    
    Abstract available

  121. C K, Kannan Karur A, C C, V P, et al
    Knowledge, Attitudes, and Practices of Medical Professionals Regarding Cervical Cancer Prevention and Human Papillomavirus (HPV) Vaccination: A Cross-Sectional Study.
    Cureus. 2025;17:e91754.
    PubMed    
    Abstract available

  122. WANG Y, Wu D, Gai J, Cai Y, et al
    Elevated VAMP8 expression promotes cervical cancer progression by enhancing autophagy via HIF-1 pathway.
    BMC Med. 2025;23:544.
    PubMed    
    Abstract available

  123. PEI K, Xi M
    The effect of marital status on cervical cancer related prognosis: a propensity score matching study.
    Sci Rep. 2025;15:35166.
    PubMed    
    Abstract available

  124. BAYISA K, Chibsa SE, Tesfaye H, Kefeni BT, et al
    Cervical cancer screening utilization and associated factors among women living with HIV in South West Ethiopia.
    Sci Rep. 2025;15:35081.
    PubMed    
    Abstract available

  125. SU L, Xu R, Ren Y, Meng C, et al
    Smoking exposure and cervical cancer risk: Integrating observational and genetic evidence.
    J Int Med Res. 2025;53:3000605251383687.
    PubMed    
    Abstract available

  126. HAYASHI R, Hara A, Iwasa Y
    Human papillomavirus driving cervical cancer: A mathematical model with persistent infection, cancer progression, and spontaneous remission.
    J Theor Biol. 2025 Oct 6:112289. doi: 10.1016/j.jtbi.2025.112289.
    PubMed    
    Abstract available

  127. KAVUMA A, Kibudde S, Kanyike DM, Luutu I, et al
    Impact of Waiting Time and Treatment Duration on Short-Term Outcomes for Patients With Locally Advanced Cervical Cancer at the Uganda Cancer Institute: The Challenges in Resource-Limited Settings.
    JCO Glob Oncol. 2025;11:e2500325.
    PubMed    
    Abstract available

  128. ZHANG T, Gu F, Li W, Han R, et al
    Characterization of cervical microbiota in cervical intraepithelial neoplasia and cervical cancer using low-coverage whole genome sequencing.
    Microbiol Spectr. 2025 Oct 8:e0320624. doi: 10.1128/spectrum.03206.
    PubMed    
    Abstract available

  129. FENG S, Yin Y, Guo H, Li D, et al
    Leukemoid Reaction and Sudden Hearing Loss in Early Cervical Cancer: A Case Report and Review of the Literature.
    Int J Womens Health. 2025;17:3417-3422.
    PubMed    
    Abstract available

  130. RYCHLIK A, Bedynska M, Querleu D
    Correspondence on "Robotic radical hysterectomy for cervical cancer: current trends and controversies".
    J Cancer. 2025;16:3897-3898.
    PubMed    


  131. JIANG L, Okada A, Ishida R, Yasunaga H, et al
    Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study.
    J Obes. 2025;2025:3691654.
    PubMed    
    Abstract available

  132. SVINTSITSKA A, Lygyrda N, Svintsitskyi V, Borikun T, et al
    INTERPLAY OF EPIGENETIC REGULATION OF KI-67 AND P53 BY MIR-21 AND MIR-34A IN CERVICAL INTRAEPITHELIAL NEOPLASIA.
    Exp Oncol. 2025;47:223-229.
    PubMed    
    Abstract available

  133. HALDER P, Sharma D, Behera A, Aggarwal AK, et al
    Decomposition analysis of coverage of cervical cancer screening among Indian women within reproductive age-group: distribution and determinants of socioeconomic inequalities using a nationally representative survey.
    Reprod Health. 2025;22:188.
    PubMed    
    Abstract available

  134. KUGUYO O, Matimba A, Tsikai N, Madziyire M, et al
    Association between human papillomavirus and behaviour, clinicopathology, and cervical cancer outcome in Zimbabwean women: a cross-sectional study.
    Reprod Health. 2025;22:190.
    PubMed    
    Abstract available

  135. YE Y, Hu X, Zhang X, Xu X, et al
    A prospective longitudinal study of the changes in multidimensional fatigue and its associated factors in patients undergoing brachytherapy for cervical cancer.
    Sci Rep. 2025;15:34831.
    PubMed    
    Abstract available

  136. TITUS MK, Giesbrecht D, Oduor CI, Muthoka K, et al
    Scalable long-read nanopore HPV16 amplicon-based whole-genome sequencing.
    Sci Rep. 2025;15:34892.
    PubMed    
    Abstract available

  137. MA C, Lu X, Ni C, Gao Y, et al
    SLC25A10 promotes cisplatin resistance by inhibiting ferroptosis in cervical cancer.
    Cell Death Discov. 2025;11:447.
    PubMed    
    Abstract available

  138. NIE R, Ma Z, Rui X, Li T, et al
    HPV vaccination willingness and behavior among nursing female students in China based on the protection motivation theory: A cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2569738.
    PubMed    
    Abstract available

  139. DENG L, Zhang R, Lv H, Li F, et al
    Multi-parametric MRI Radiomics models for preoperative assessment of lymph vascular space invasion status in early-stage cervical cancer: A two-center retrospective study.
    Br J Radiol. 2025 Oct 7:tqaf248. doi: 10.1093.
    PubMed    
    Abstract available

  140. RUBEN C, Narasimhan S, Nolan E
    EBM BLS: Self-collected Human Papillomavirus Cervical Cancer Screening Is Non-Inferior to Clinician-Collected Samples.
    J Gen Intern Med. 2025 Oct 7. doi: 10.1007/s11606-025-09830.
    PubMed    


  141. SCHEEPERS VC, Gardner J
    Expanding the case for gender-neutral human papillomavirus vaccination in South Africa: Emerging neonatal and ethical considerations.
    Afr J Prim Health Care Fam Med. 2025;17:e1-e3.
    PubMed    
    Abstract available

  142. ZHU L, Pu J, Tao Y, Shi L, et al
    A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses.
    Cancer Biol Med. 2025;22:1102-26.
    PubMed    
    Abstract available

  143. MA S, Sun K, Han B, Zheng R, et al
    Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals.
    Cancer Biol Med. 2025;22:1017-35.
    PubMed    
    Abstract available

  144. ZHONG P, Zhang L, Zhao F
    Modeling cervical cancer elimination: a pathway to inform policy decisions.
    Cancer Biol Med. 2025;22:1002-9.
    PubMed    


  145. REZHAKE R, Abuduxikuer G, Abudurexiti G, Zhuo Q, et al
    Evaluation of the multiple HPV-based "screen and triage" algorithms in real-world settings of rural China.
    Cancer Biol Med. 2025;22:1053-67.
    PubMed    
    Abstract available

  146. CHEN M, Ma J, Wu Y, Hu H, et al
    Accelerating the elimination of global cervical cancer through intelligent training for colposcopy.
    Cancer Biol Med. 2025;22:1036-52.
    PubMed    
    Abstract available

  147. KAMIJO S, Matsuda R, Yamada M, Nishio H, et al
    Outcomes of assisted reproductive technology after radical abdominal trachelectomy for early-stage cervical cancer.
    F S Rep. 2025;6:299-308.
    PubMed    
    Abstract available

  148. TALI H, Yeerjiang K, Zeng BB, Rui T, et al
    Barriers to cervical cancer prevention and triage strategies: a study of knowledge, attitudes, and p16/Ki-67 dual-staining utility among high-risk women in Tuoli and Fuyun counties, Xinjiang.
    PeerJ. 2025;13:e20100.
    PubMed    
    Abstract available

  149. QI H, Liu X, Sun J, Dong L, et al
    Key cell cycle genes in cervical cancer and their potential role in neuromuscular complications: a bioinformatics perspective.
    Eur J Transl Myol. 2025 Oct 6. doi: 10.4081/ejtm.2025.14127.
    PubMed    
    Abstract available

  150. TOGAMI S, Furuzono N, Kobayashi Y, Fukuda M, et al
    Fertility-Sparing Trachelectomy With Sentinel Node Mapping in Early-Stage Cervical Cancer: Oncological Safety and Obstetric Outcomes From a Single-Institution Study.
    J Obstet Gynaecol Res. 2025;51:e70091.
    PubMed    
    Abstract available

  151. ZHANG X, Li M, Wang K, Sun Z, et al
    A histone acetylation-based predictive model for immunotherapy response and combinatorial targeting in cervical cancer.
    Medicine (Baltimore). 2025;104:e44946.
    PubMed    
    Abstract available

  152. XING G, Lu Y, Zhang C, Sun X, et al
    Primary vaginal adenocarcinoma as a radiation-associated secondary malignancy: A case report and comprehensive literature review.
    Medicine (Baltimore). 2025;104:e44272.
    PubMed    
    Abstract available

  153. ZHU M, Zhang Y, Bao X, Zhu H, et al
    Association between childhood adiposity and gynecologic cancers: a mendelian randomization analysis.
    BMC Womens Health. 2025;25:470.
    PubMed    
    Abstract available

  154. AYNALEM BY, Anteneh KT, Enyew MM
    Knowledge, attitudes, and associated factors of cervical cancer screening among women in Debre Markos town, Northwest Ethiopia: a cross-sectional study.
    Sci Rep. 2025;15:34726.
    PubMed    
    Abstract available

  155. SWASE TD, Agunloye MO, Ifie JE, Shinkafi TS, et al
    The Impact of Antiretroviral Therapy (ART) on HPV Persistence and Cervical Cancer Progression Among Women with HPV/HIV Co-infection: A Systematic Review.
    AIDS Behav. 2025 Oct 6. doi: 10.1007/s10461-025-04835.
    PubMed    
    Abstract available

  156. HU J, Wang H, Zhao S, Huang L, et al
    Participation, knowledge, and attitudes toward cervical cancer screening among migrant Burmese women on China-Myanmar border: a cross-sectional study.
    Prev Med Rep. 2025;58:103205.
    PubMed    
    Abstract available

  157. WEI ZT, Yu XW, He JX, Liu Y, et al
    Erratum: [Corrigendum] Characteristics of primary side population cervical cancer cells.
    Oncol Lett. 2025;30:547.
    PubMed    
    Abstract available

  158. TAHA H, Alhawamdeh T, Alkhaldi SM, Ali Albsoul R, et al
    Knowledge and attitudes of medical students regarding human papilloma virus infection and vaccine: cross-sectional study from Jordan.
    Front Cell Infect Microbiol. 2025;15:1657090.
    PubMed    
    Abstract available

  159. GU X, Luo Y, Lai C, Liu Y, et al
    Analysis of Risk Factors of Lymphedema After Surgical Treatment in Cervical Cancer: A Case-Control Retrospective Study.
    Int J Gen Med. 2025;18:5927-5938.
    PubMed    
    Abstract available

  160. WU F, Tang X, Liu W, Luo Z, et al
    Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.
    Ther Adv Med Oncol. 2025;17:17588359251379397.
    PubMed    
    Abstract available

  161. MACHABA SIKHWETHA MC, Makhado L
    Experiences of women living with HIV who underwent long loop excision of the transformation zone (LLETZ) in selected hospitals of Vhembe district, Limpopo province, South Africa.
    F1000Res. 2025;14:382.
    PubMed    
    Abstract available

  162. WEN W, Li J, Yuan L, Liao Y, et al
    PRDX3 Promotes Lymph Node Metastasis in Cervical Cancer by Activating NF-kappaB Signaling Pathway and Anoikis Resistance.
    Int J Med Sci. 2025;22:3839-3853.
    PubMed    
    Abstract available

  163. CHIBA T, Nakamura S, Nakayama H, Iijima K, et al
    Dosimetric impact of dose constraint indications using individual patient dose management system for brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2025;17:255-266.
    PubMed    
    Abstract available

  164. ELBANNA M, Agrawal N, Holmes JA
    Predictors of interstitial brachytherapy utilization in locally advanced cervical cancer and impact on overall survival.
    J Contemp Brachytherapy. 2025;17:248-254.
    PubMed    
    Abstract available

  165. HAO F, Xiao N, Wang M, Sang H, et al
    Clinical Prognostic Factors for Overall Survival in Patients Undergoing Radical Radiotherapy for Cervical Cancer.
    Int J Womens Health. 2025;17:3347-3359.
    PubMed    
    Abstract available

  166. MUSHASHA MP, Modiba LM
    Awareness among nurses concerning the human papilloma virus in the selected clinics in Vhembe district of Limpopo Province, South Africa.
    Front Public Health. 2025;13:1627425.
    PubMed    
    Abstract available

  167. OU Y, Chokkakula S, Chong SM, Wang H, et al
    Age and socioeconomic disparities in cervical cancer incidence and mortality: a SEER-based analysis.
    Front Public Health. 2025;13:1591883.
    PubMed    
    Abstract available

  168. ASOUDEH-FARD A, Parsaei A, Hejazian SM, Asoudeh-Fard M, et al
    Combinational therapy of cervical cancer consisting of probiotic particles and vincristine: a molecular in vitro study.
    Med Oncol. 2025;42:509.
    PubMed    
    Abstract available

  169. ARAGAW GM, Aynalem GL, Abiy SA, Taye EB, et al
    Knowledge and attitude of parents towards the human papillomavirus vaccine for their daughters and associated factors in Debre Tabor town, northwest Ethiopia: a community-based cross-sectional study.
    BMJ Open. 2025;15:e088550.
    PubMed    
    Abstract available

  170. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Corrigendum to "Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa" [Vaccine 64 (2025) 127770].
    Vaccine. 2025;65:127797.
    PubMed    


  171. NIRMALKAR AP, Shahabuddin SM, Mahajan US, Mamulwar MS, et al
    Cervical Cancer Screening Methods among Women Living with Human Immunodeficiency Virus: A Systematic Review and Meta-analysis.
    Indian J Public Health. 2025;69:321-331.
    PubMed    
    Abstract available

  172. BONATTI M, Valletta R, D'Erme L, Dolciami M, et al
    Preoperative staging of cervical cancer: time to shift from cystoscopy to MRI.
    Eur Radiol. 2025 Oct 4. doi: 10.1007/s00330-025-12039.
    PubMed    
    Abstract available

  173. HUANG Y, Zhong Y, Lu H, Jin K, et al
    In Situ Construction of Upconverting Nano-Bacteria Biohybrids via Biomimetic Mineralization for Synergistic Antitumor Phototherapy.
    ACS Appl Mater Interfaces. 2025;17:56006-56016.
    PubMed    
    Abstract available

  174. WEI J, Zou K, Sun F, Feng Q, et al
    18 F-FAPI-04 PET/CT in the Evaluation of Patients With Cervical Cancers : Head-to-Head Comparison With 18 F-FDG PET/CT.
    Clin Nucl Med. 2025 Aug 21. doi: 10.1097/RLU.0000000000006103.
    PubMed    
    Abstract available

  175. GUAN W, Liu S, Chen Y, Chu C, et al
    HPVPool-Seq: a genotype-guided pooling strategy for cost-effective next-generation sequencing detection of HPV integration in cervical samples.
    Microbiol Spectr. 2025;13:e0139925.
    PubMed    
    Abstract available

  176. GUILLAUME D, Alcaide ML, Sternberg CA, Hay J, et al
    Contextualizing HPV vaccination intention among Haitian immigrant and migrant women through exploring cultural worldviews and affective risk perception: a qualitative study.
    Ethn Health. 2025;30:806-823.
    PubMed    
    Abstract available

  177. BEFANO B, Kalpathy-Cramer J, Egemen D, Inturrisi F, et al
    Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus-Automated Visual Evaluation Consortium.
    J Natl Cancer Inst. 2025;117:2124-2129.
    PubMed    
    Abstract available

  178. PRITCHARD AG, Altas M, Tinker AV, Kong I, et al
    Long-Term Toxicities of Adolescent and Young Adults Who Underwent Radiation Therapy for Cervix Cancer: A Cross-Sectional Analysis.
    J Adolesc Young Adult Oncol. 2025;14:392-400.
    PubMed    
    Abstract available

  179. LIU L, Storino M, Chen YS, Walker A, et al
    Mesonephric and Mesonephric-like Adenocarcinomas of the Gynecologic Tract: A Case Series and a Review of the Literature.
    Int J Gynecol Pathol. 2025;44:553-560.
    PubMed    
    Abstract available

  180. PRADHAN P, Iyer HS, Rebbeck TR
    Geographic and Temporal Patterns of Screening for Breast, Cervical, and Colorectal Cancer in the US, 1997-2019.
    JAMA Netw Open. 2025;8:e2537905.
    PubMed    
    Abstract available

  181. LU L, Li Z, Qiang P, Shao Y, et al
    Gut microbiota and risk of cervical cancer: a Mendelian multivariable randomization study.
    Discov Oncol. 2025;16:1912.
    PubMed    
    Abstract available

  182. YANG S, Zeng L, Deng C, Tian X, et al
    Anti-tumor Effects of Hedyotis diffusa Willd on Cervical Cancer: Inhibition of Proliferation, Migration, and Induction of Apoptosis.
    Iran J Pharm Res. 2025;24:e159390.
    PubMed    
    Abstract available

  183. MURTAS M, Rolland-Guillard L, Hu K, Wisniak A, et al
    [HPV self-sampling and cervical cancer screening].
    Rev Med Suisse. 2025;21:1827-1831.
    PubMed    
    Abstract available

  184. MORIASI G, Ngugi M, Mwitari P, Omwenga G, et al
    Promising anti-cervical cancer efficacy and phytochemical analysis of Vitex doniana Sweet (Verbenaceae) leaf extracts: an in vitro investigation with molecular mechanisms of action.
    BMC Complement Med Ther. 2025;25:379.
    PubMed    
    Abstract available

  185. MATHIBELA SP, Ncube KN, Lebelo MT, Steenkamp V, et al
    Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology.
    J Cancer Res Clin Oncol. 2025;151:294.
    PubMed    
    Abstract available

  186. MOHAMMADI MM, Karimi Z, Shirani M, Elyasi S, et al
    A model testing study of cervical cancer screening behavior using rogers's protection motivation theory.
    Sci Rep. 2025;15:36260.
    PubMed    
    Abstract available

  187. HUANG S, Wang R, Song Y, Liao S, et al
    Uncovering the anti-cervical cancer mechanism of Ziyuglycoside I via integrated network pharmacology molecular docking and experimental validation.
    Sci Rep. 2025;15:36258.
    PubMed    
    Abstract available

  188. CHEN Z, Lin E, Chen M, Wang S, et al
    Temporal Trends in Cervical Human Papillomavirus Prevalence Among Females in Xiamen, China (2016-2023): Cross-Sectional Study.
    JMIR Public Health Surveill. 2025;11:e70507.
    PubMed    
    Abstract available

  189. GARASZCZUK R, Yong JHE, Coldman A, Garner R, et al
    The OncoSim-Cervix cancer microsimulation model: Unveiling roll-out strategies for human papillomavirus primary testing.
    Health Rep. 2025;36:15-26.
    PubMed    
    Abstract available

  190. YANG XL, Wei LC, He JL, Wang TJ, et al
    Different prognosis for stage IIB cervical cancer patients with unilateral or bilateral parametrial invasion treated with concurrent chemoradiotherapy.
    Oncologist. 2025 Oct 16:oyaf329. doi: 10.1093.
    PubMed    
    Abstract available

  191. YANG J, Ji J, Ni X, Li Y, et al
    Explorations of predictors for parametrial invasion and how it affects treatment strategy for bulky cervical cancer.
    Front Oncol. 2025;15:1660495.
    PubMed    
    Abstract available

  192. PAVARINO TTG, Guimaraes ICCDV, Oliveira CA, Viviani SCA, et al
    The occurrence of cervical high-grade lesions in women outside the recommended age screening.
    Rev Bras Ginecol Obstet. 2025;47:e-rbgo41.
    PubMed    
    Abstract available

  193. WASHINGTON A, Houck KF, Nelson BW, Harper DM, et al
    Black US women share their experiences with follow-up after abnormal cervical cancer screening.
    Public Health Pract (Oxf). 2025;10:100658.
    PubMed    
    Abstract available

  194. CHEN R, Ye C, Li Y, Lin Z, et al
    The distribution of colposcopy directed ectocervical biopsy and endocervical curettage results: a retrospective study of 47,134 cases.
    Ann Med. 2025;57:2573149.
    PubMed    
    Abstract available

  195. YOUSEFIRIZI F, Hajianfar G, Sabouri M, Holloway C, et al
    Pre-Treatment PET Radiomics for Prediction of Disease-Free Survival in Cervical Cancer.
    Cancers (Basel). 2025;17:3218.
    PubMed    
    Abstract available

  196. GALANI A, Zikopoulos A, Moustakli E, Potiris A, et al
    Cervical Cancer Screening in the HPV-Vaccinated and Digital Era: Reassessing Strategies in Light of Artificial Intelligence and Evolving Risk.
    Cancers (Basel). 2025;17:3179.
    PubMed    
    Abstract available

  197. BAUTISTA-SEBASTIAN E, Cortes-Morales VA, Fajardo-Orduna GR, Monroy-Garcia A, et al
    Interaction Between Mesenchymal Stromal Cells and Tumor Cells Present in Cervical Cancer Influences Macrophage Polarization.
    Cancers (Basel). 2025;17:3099.
    PubMed    
    Abstract available

  198. ARIZMENDI-IZAZAGA A, Navarro-Tito N, Campos-Viguri GE, Jimenez-Wences H, et al
    Exometabolome and Molecular Signatures Associated with HPV 16 in Cervical Cancer: Integrative Metabolomic and Transcriptomic Analysis for Biomarker Discovery.
    Molecules. 2025;30:3909.
    PubMed    
    Abstract available

  199. COSTA MT, Neto BV, da Silva JB, Carvalho L, et al
    Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior.
    Int J Mol Sci. 2025;26:9796.
    PubMed    
    Abstract available

  200. MEDINA BUENO GA, Jaramillo Saavedra EA, Torres Rendon N, Huareccallo Suni DD, et al
    Predictive Factors for Cervical Intraepithelial Neoplasia in Women with Abnormal Cytology According to Human Papillomavirus Genotype: An Observational Study.
    Int J Mol Sci. 2025;26:9612.
    PubMed    
    Abstract available

  201. MAIMON T, Trink Y, Goldberger J, Kalisky T, et al
    Unsupervised Machine Learning Reveals Temporal Components of Gene Expression in HeLa Cells Following Release from Cell Cycle Arrest.
    Int J Mol Sci. 2025;26:9491.
    PubMed    
    Abstract available

  202. LADOUKAKIS E, Andriamiadana G, Hajizadah F, James LGE, et al
    Epigenetic Biomarkers for Cervical Cancer Progression: A Scoping Review.
    Int J Mol Sci. 2025;26:9423.
    PubMed    
    Abstract available

  203. ESPIAS-ALONSO M, Gorostidi M, Zapardiel I, Gracia M, et al
    Assessment of ESGO Quality Indicators and Factors Associated with Recurrence Following Surgery for Early-Stage Cervical Cancer: A Retrospective Cohort Study.
    J Clin Med. 2025;14:7041.
    PubMed    
    Abstract available

  204. ALMARS AI
    Green-synthesized MnFe(2)O(4)/GO nanocomposites: structural characterization, cytotoxicity, and potential for targeted cervical cancer therapy.
    Cancer Cell Int. 2025;25:355.
    PubMed    
    Abstract available

  205. SASSENOU J, Ringa V, Zins M, Ozguler A, et al
    Underuse, overuse, and guideline-based use of cervical cancer screening: social disparities in temporal screening trajectories in the French CONSTANCES cohort.
    BMC Womens Health. 2025;25:495.
    PubMed    
    Abstract available

  206. DAVID C, El-Zein M, Franco EL, Szyf M, et al
    Enhancing the sensitivity of non-invasive cervical cancer detection using CpG methylation haplotype profiling.
    Sci Rep. 2025;15:36057.
    PubMed    
    Abstract available

  207. PY JF, Renard S, Gehin W, Martz N, et al
    Good safety of oblique needle insertion using the Venezia applicator for cervical cancer: A single-center cohort study.
    Brachytherapy. 2025 Oct 14:S1538-4721(25)00304.
    PubMed    
    Abstract available

  208. BIXEL K
    Sentinel Lymphadenectomy for Early-Stage Cervical Cancer - the New Standard?
    N Engl J Med. 2025;393:1534-1536.
    PubMed    


  209. TU H, Huang H, Li Y, Chen X, et al
    Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.
    N Engl J Med. 2025;393:1463-1474.
    PubMed    
    Abstract available

  210. YERRAM PS, Mwita CJ, Mwaiselage J, Elul B, et al
    Association Between the Test-and-Treat Strategy and the Severity of Cervical Dysplastic Lesions Among Women Living With HIV in Tanzania (2015-2023).
    JCO Glob Oncol. 2025;11:e2400540.
    PubMed    
    Abstract available

  211. SOZIB SI, Smail L, Jassim GA
    Knowledge, attitudes, and practices regarding HPV infection, cervical cancer, and HPV vaccination among Emirati women.
    Future Oncol. 2025 Oct 15:1-11. doi: 10.1080/14796694.2025.2575519.
    PubMed    
    Abstract available

  212. KIETPEERAKOOL C, Rattanakanokchai S, Shawky M, Morrison J, et al
    Simple hysterectomy with pelvic lymphadenectomy versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2-IB1 cervical cancer.
    Cochrane Database Syst Rev. 2025;10:CD012335.
    PubMed    
    Abstract available

  213. WANG F, Jiang X, Wang P
    [Retracted] NF-kappaB interaction long non-coding RNA inhibits migration, invasion and epithelial-mesenchymal transition of cervical cancer cells through inhibiting NF-kappaB signaling pathways.
    Exp Ther Med. 2025;30:234.
    PubMed    
    Abstract available

  214. ALTUNTAS CALIM G, Elmas S
    Do women's personality traits influence their beliefs about cervical cancer screening: a descriptive-correlational study in a sample from Turkiye.
    BMC Psychol. 2025;13:1141.
    PubMed    
    Abstract available

  215. ZENG S, Hu L, Ding W, Cao X, et al
    The most common combination of co-infections genotypic distribution and clearance patterns of high-risk human papillomavirus in Southern China: a population-based retrospective study.
    Virol J. 2025;22:327.
    PubMed    
    Abstract available

  216. ZHOU J, Su LJ, Chen J, Hu HB, et al
    Cervical conization and high risk - HPV status changes in relation to menopause: a retrospective longitudinal study based on generalized additive mixed models.
    BMC Infect Dis. 2025;25:1322.
    PubMed    
    Abstract available

  217. CHARGARI C, Ducassou A, Laville A, Lucia F, et al
    Radiotherapy and brachytherapy for cervical cancer: Recommendations of the Societe francaise de radiotherapie oncologique.
    Cancer Radiother. 2025;29.
    PubMed    
    Abstract available

  218. RAMAKRISHNAN P, Blomker J, Cooke K, Bowler T, et al
    Cervical cancer screening remains low in liver transplant patients regardless of demographics: A single-center review.
    Liver Transpl. 2025 Oct 14. doi: 10.1097/LVT.0000000000000748.
    PubMed    


  219. LI Y, Wei X, Li Y
    Recombinant lactococcus lactis expressing HPV-16 E6E7 dual antigens for potential cervical cancer treatment enhances dendritic cell vaccines efficacy.
    Future Microbiol. 2025 Oct 14:1-11. doi: 10.1080/17460913.2025.2567700.
    PubMed    
    Abstract available

  220. ZHANG C, Jia D, Wang Z
    Computer-assisted quantitative framework for whole slide cervical image grading driven by time series features.
    Sci Rep. 2025;15:35596.
    PubMed    
    Abstract available

  221. ZHAO Q, Ruan G, Ye Z, Meng Y, et al
    County-level colposcopy attendance in China's national cervical cancer screening programme: a cross-sectional ecological study of Fujian province.
    BMJ Open. 2025;15:e101866.
    PubMed    
    Abstract available

  222. CAMDZIC N, Brkic A, Mameledzija E, Babic M, et al
    Prevalence of cervical cytology abnormalities and its correlation with human papillomavirus infection: a single- institution five-year experience.
    Med Glas (Zenica). 2025;22:258-262.
    PubMed    
    Abstract available

  223. ZHEN Q, Xu Y, Xu Y, Liu X, et al
    Erucic Acid, Derived by Lactobacillus Crispatus, Induces Ferroptosis in Cervical Cancer Organoids Through the PPAR-delta Signaling Pathway.
    Adv Sci (Weinh). 2025 Oct 13:e12599. doi: 10.1002/advs.202512599.
    PubMed    
    Abstract available

  224. RAHIMI-MOGHADDAM A, Ghorbanmehr N, Gharbi S
    Dual Inhibition of PI3K-AKT Signaling Pathway by miR-542 Overexpression in Cervical Cancer.
    Biochem Genet. 2025 Oct 13. doi: 10.1007/s10528-025-11257.
    PubMed    
    Abstract available

  225. LAHOUTI S, Doustvandi MA, Yari A, Eslami M, et al
    Photodynamic therapy boosts the anti-proliferative activity of oxaliplatin in cervical cancer cells by regulating stemness-related genes.
    Med Oncol. 2025;42:514.
    PubMed    
    Abstract available

  226. YANG Y, Shi W, Zhang M, Gong X, et al
    Cervical morphology and elasticity following treatment of cervical squamous intraepithelial lesions with focused ultrasound vs. loop electrosurgical excision procedure: a prospective non-randomized controlled study.
    Int J Hyperthermia. 2025;42:2570825.
    PubMed    
    Abstract available

  227. MEI W, Li C, Tang Q, Sang L, et al
    Prospective comparison of synthetic high b-value field of view optimized and constrained undistorted multiplexed sensitivity encoding (FOCUS-MUSE) and FOCUS diffusion-weighted imaging in evaluating cervical cancer.
    Quant Imaging Med Surg. 2025;15:10006-10019.
    PubMed    
    Abstract available

  228. LIU L, Pan L, Zou C, Zhang F, et al
    Reliability study of MRI in detecting lymph node metastasis of cervical cancer: a multi-center retrospective study result analysis.
    Quant Imaging Med Surg. 2025;15:9559-9570.
    PubMed    
    Abstract available

  229. YUAN Y, Sun D, Yang M, Xia Y, et al
    Profiling of immune cell subsets and functional characteristics of cervical cancer based on single cell RNA sequencing.
    Front Immunol. 2025;16:1658705.
    PubMed    
    Abstract available

  230. NJANGIRU IK, Tayeb BA, Ali H, Kamil RM, et al
    Liquid biopsy biomarkers in cervical cancer: A systematic review and meta-analysis.
    J Liq Biopsy. 2025;10:100328.
    PubMed    
    Abstract available

  231. LIU Y, Shi Y, Zhang Y, Hua K, et al
    A novel bivariate nomogram for predicting sequela vaginal lesions after surgery in patients with HPV-associated cervical cancer.
    Front Oncol. 2025;15:1587520.
    PubMed    
    Abstract available

  232. HUANG G, Ye X, Chen X
    The Efficacy of Evidence-Based Nursing Interventions in Postoperative Care for Cervical Cancer Patients: A Retrospective Evaluation.
    Int J Gen Med. 2025;18:6073-6082.
    PubMed    
    Abstract available

  233. TUNINETTI V, Virano E, Calvo A, Carbone V, et al
    Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With Cemiplimab.
    J Cachexia Sarcopenia Muscle. 2025;16:e70101.
    PubMed    
    Abstract available

  234. PENG X, Zhu Y, Han Y, Cai C, et al
    Enhancing anti-tumor immunity by targeting BATF and the STAT1/PD-L1 pathway in cervical carcinoma.
    Cell Mol Life Sci. 2025;82:353.
    PubMed    
    Abstract available

  235. ZHANG Y, Lu J, Qi M, Zhang X, et al
    CDK11 Promotes Paclitaxel Resistance in Cervical Cancer by Regulating LATS1-Mediated Hippo Signaling Pathway Through Phosphorylation of NF2.
    FASEB J. 2025;39:e71085.
    PubMed    
    Abstract available


  236. Corrigendum to: CerviNet: A Novel Approach for Cervical Cancer Classification Using Pap-Smear Images.
    J Comput Biol. 2025;32:986.
    PubMed    


  237. PELLEGRINO RA, Tu S, Ville-Benavides R, Jalil EM, et al
    Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study.
    J Int AIDS Soc. 2025;28:e70050.
    PubMed    
    Abstract available

  238. LIU M, Huang X, Feng Q
    Human Papillomavirus 42: A Novel Sublineage Identification, and Comparative Analysis of HPV42 Genetic Variability Present in Cervical Cell and Digital Papillary Adenocarcinoma.
    J Med Virol. 2025;97:e70640.
    PubMed    
    Abstract available

  239. ZHAO Y, Zhao C, Zhao J, Ma Y, et al
    Excavation of Molecular Subtypes of Cervical Cancer Based on DNA Methylation Patterns.
    Front Biosci (Landmark Ed). 2025;30:45025.
    PubMed    
    Abstract available

  240. YE M, Yan D, Xu J, Liu D, et al
    Human papillomavirus prevalence and genotype distribution among 30,147 screened women and 3,362 cervical cancer patients in China: a retrospective study.
    Virol J. 2025;22:323.
    PubMed    
    Abstract available

  241. SILVA LGSD, Silva PVS, Chaves MFD, Cruz ACDC, et al
    Interval between diagnosis and treatment of cervical cancer in Brazil: comparative analysis of cases with and without diagnosis prior to arrival at the hospital unit.
    BMC Womens Health. 2025;25:485.
    PubMed    
    Abstract available

  242. LEMA TF, Moleki M, Mosalo A
    Epidemiology of human papillomavirus infection of the uterine cervix among women in Adama, Ethiopia: a cross-sectional study.
    BMC Infect Dis. 2025;25:1277.
    PubMed    
    Abstract available

  243. WANG Z, Yun Q, Zhang T, Sun X, et al
    Dosimetric advantages of a novel X-Ray/gamma-Ray integrated radiotherapy platform in cervical carcinoma: A comparative treatment planning study.
    Phys Med. 2025;138:105098.
    PubMed    
    Abstract available

  244. SEVILLA-DEDIEU C, Le Guern M, Coquoz C, Billaudeau N, et al
    Which women go for screening?
    Eur J Public Health. 2025;35:992-998.
    PubMed    
    Abstract available

  245. ISHIGURO T, Saida T, Minami M, Mori K, et al
    MRI localization evaluation to distinguish gastric-type adenocarcinoma and lobular endocervical glandular hyperplasia from other cystic lesions.
    Br J Radiol. 2025 Aug 4:tqaf191. doi: 10.1093.
    PubMed    
    Abstract available

  246. LUCAS E, Dimitrova N, Tomatis M, Sheridan B, et al
    Creating a data processing warehouse to support performance monitoring of cancer screening programmes in Europe using a common set of indicators.
    Eur J Public Health. 2025;35:977-983.
    PubMed    
    Abstract available

  247. JIMENEZ NR, Mancilla V, Laniewski P, Herbst-Kralovetz MM, et al
    Immunometabolic Contributions of Atopobiaceae Family Members in Human Papillomavirus Infection, Cervical Dysplasia, and Cancer.
    J Infect Dis. 2025;232:767-778.
    PubMed    
    Abstract available

  248. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Self efficacy as a key mediator for cervical cancer screening behavior.
    Sci Rep. 2025;15:37090.
    PubMed    
    Abstract available

  249. TRUONG R, Moore LC, Mitra A, Kallis K, et al
    Integration of single-click, AI-based brachytherapy auto-planning for cervical cancer within a treatment planning system.
    Brachytherapy. 2025 Oct 22:S1538-4721(25)00297.
    PubMed    
    Abstract available

  250. RUAN Y, Liu X, Li Y, Fu A, et al
    A risk prediction model for cervical cancer in adults: A study based on the national health interview survey (NHIS) 2019-2023.
    J Natl Med Assoc. 2025 Oct 22:S0027-9684(25)00330.
    PubMed    
    Abstract available

  251. TSAI YL, Wang HJ, Chen SI, Chang JY, et al
    Impact of COVID-19 on cervical cancer screening: A cohort study.
    J Formos Med Assoc. 2025 Oct 22:S0929-6646(25)00574.
    PubMed    
    Abstract available

  252. ZHU EJ, Bu XS, Yue Y, Hou YS, et al
    Design, synthesis and biological evaluation of novel HIF-1alpha PROTACs degrader as potent anti-cervical cancer agents.
    Bioorg Med Chem Lett. 2025 Oct 21:130443. doi: 10.1016/j.bmcl.2025.130443.
    PubMed    
    Abstract available

  253. PENA-MANRIQUE I, Maclin BJ, Kreimer AR, Alraqiq H, et al
    Knowledge that HPV can cause oropharyngeal cancer and cervical cancer among adults in the United States: A comparison of prevalence and predictors.
    Public Health. 2025;249:106006.
    PubMed    
    Abstract available

  254. PEKYUREK VARAN M, Yaprak G, Gunduz K, Yetmen Dogan O, et al
    Investigation of potential biomarkers associated with relapse in cervical cancer: miRNA-320a-3p and miRNA-136-5p.
    Strahlenther Onkol. 2025 Oct 23. doi: 10.1007/s00066-025-02476.
    PubMed    
    Abstract available

  255. BAUTISTA J, Altamirano-Colina A, Lopez-Cortes A
    The vaginal microbiome in HPV persistence and cervical cancer progression.
    Front Cell Infect Microbiol. 2025;15:1634251.
    PubMed    
    Abstract available

  256. WESTERHOFF T, Baudoux N, Undurraga M, Petignat P, et al
    Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series.
    Gynecol Oncol Rep. 2025;61:101967.
    PubMed    
    Abstract available

  257. LI M, Gao N, Xu L, Ge P, et al
    Integrative RNA-seq and LASSO-COX analysis reveal Paeonol's key target gene in proliferation suppression and apoptosis-induced in cervical cancer.
    Front Pharmacol. 2025;16:1646473.
    PubMed    
    Abstract available

  258. FALLAH PN, Medley N, Birara Fanta M, Shaki MH, et al
    Challenges and Opportunities in the Treatment of Invasive Cervical Cancer in Low-Resource Settings: A Survey of the International Gynecologic Cancer Society Fellowship Programs.
    JCO Glob Oncol. 2025;11:e2500015.
    PubMed    
    Abstract available

  259. BAI Y, Devlin RA, Habbous S, Jaakkimainen L, et al
    Physician payment models and preventive cancer screening: a population-based retrospective cohort analysis from Ontario, Canada.
    Fam Pract. 2025;42:cmaf076.
    PubMed    
    Abstract available

  260. AMBOREE TL, Adsul P, Damgacioglu H, Schmeler KM, et al
    National Outcomes of Increasing Cervical Cancer Screening in Federally Qualified Health Centers.
    JAMA Netw Open. 2025;8:e2538593.
    PubMed    
    Abstract available

  261. AIOB A, Gumin D, Sharon A, Lowenstein L, et al
    Mini-laparotomic-assisted laparoscopic radical hysterectomy: an innovative technique for cervical cancer surgery-a case series.
    Arch Gynecol Obstet. 2025 Oct 22. doi: 10.1007/s00404-025-08224.
    PubMed    
    Abstract available

  262. KAMBLE P, Dubey K, Mukherjee A, Jain R, et al
    Decoding Cervical Cancer Biomarkers: An Integrated Framework of Bioinformatics, Machine Learning, and Experimental Confirmation.
    Cancer Invest. 2025 Oct 22:1-21. doi: 10.1080/07357907.2025.2575338.
    PubMed    
    Abstract available

  263. HU Y, Wang Z, Li F, Feng W, et al
    [The effect of CD33(+)MDSC-mediated T lymphocyte function on the therapeutic efficacy of (125)I particle implantation combined with arterial chemoembolization in the treatment of cervical cancer].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025;41:905-912.
    PubMed    
    Abstract available

  264. ZHANG Y, Zhang J, Li H, Zhuang Y, et al
    Synergistic impact of dysglycemia and HPV on cervical cancer risk: a potential mediating role of Ki-67.
    Front Endocrinol (Lausanne). 2025;16:1422881.
    PubMed    
    Abstract available

  265. YANG T, Yi Q, Gong J
    Multiparametric magnetic resonance imaging-based comprehensive model on prediction of lymphovascular space invasion in cervical cancer.
    Front Oncol. 2025;15:1578119.
    PubMed    
    Abstract available


  266. Retraction: Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
    Front Mol Biosci. 2025;12:1712894.
    PubMed    
    Abstract available

  267. XU L, Huang S, Zhu H
    A case report on SMARCA4 deficient cervical adenocarcinoma with high-grade squamous intraepithelial lesion.
    World J Surg Oncol. 2025;23:384.
    PubMed    
    Abstract available

  268. CHEN F, Bai G, Liu Q, He G, et al
    Integrated multi-omics identifies a CD54(+) iCAF-ITGAL(+) macrophage niche driving immunosuppression via CXCL8-PDL1 axis in cervical cancer.
    Mol Cancer. 2025;24:262.
    PubMed    
    Abstract available

  269. HUANG LL
    Medical futility and the ethics of continuing treatment: a hermeneutic inquiry into patient and physician perspectives.
    Philos Ethics Humanit Med. 2025;20:33.
    PubMed    
    Abstract available

  270. CARASSITI R, Jentschke M, Soergel P, Hilal Z, et al
    Cervical cancer screening by co-testing in women 35 years and older: an analysis of the 1st round of screening in Germany.
    BMC Womens Health. 2025;25:498.
    PubMed    
    Abstract available

  271. MILI MA, Hossain MJ, Poli MA, Kumar SB, et al
    Impact of health education on knowledge and perception of cervical cancer and screening among rural women in Bangladesh.
    Sci Rep. 2025;15:36812.
    PubMed    
    Abstract available

  272. SARANYA SS, Santhanakrishnan C, Kumar KPM, Kumar PA, et al
    Advancements in fusion-based deep representation learning for enhanced cervical precancerous lesion classification using biomedical image analysis.
    Sci Rep. 2025;15:36705.
    PubMed    
    Abstract available

  273. PACE LE, Uwihaye JD, Mukandayisenga V, Fata AM, et al
    Early experience scaling up a breast cancer early detection initiative integrated with cervical cancer screening in Rwanda.
    BMJ Glob Health. 2025;10:e021235.
    PubMed    
    Abstract available

  274. BOLUKBASI FB, Sahin B
    Determinants of cervical cancer incidence and mortality: A study on WHO countries.
    Health Care Women Int. 2025 Oct 21:1-22. doi: 10.1080/07399332.2025.2573648.
    PubMed    
    Abstract available

  275. TUNC M, Tekelioglu T, Akbay NA, Akilli H, et al
    Atypical Cervical Cytology in Solid-Organ Transplant Patients: 20 Years of Experience in a Single Center.
    Exp Clin Transplant. 2025;23:583-586.
    PubMed    
    Abstract available

  276. FATIMA S, Verma M, Shahab U, Ahmad S, et al
    Cimicifugic acid B, a hydroxycinnamic acid ester of Cimicifuga sp., exhibits strong antiproliferative and cytotoxic potential against cervical cancer cells.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    PubMed    
    Abstract available

  277. JIANG H, Liu L, He S, Qu S, et al
    Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor immunity by activating mtDNA-cGAS-STING pathway.
    J Biomed Sci. 2025;32:92.
    PubMed    
    Abstract available

  278. WANG Q, Yu H, Huang R
    FAM72A promotes cervical cancer progression by regulating the PI3K pathway.
    Funct Integr Genomics. 2025;25:215.
    PubMed    
    Abstract available

  279. WANG Y, Qi C, Hao M
    Development of a prognostic model for cervical cancer based on inflammation-related gene signatures and immune microenvironment regulation.
    Am J Cancer Res. 2025;15:3933-3946.
    PubMed    
    Abstract available

  280. PUROHIT N, Mishra Y, Hazarika P, Gopalakrishnan AV, et al
    Pathways to precision medicine in cervical cancer: a comprehensive review of small molecule inhibitors, biomarkers and computational approaches.
    3 Biotech. 2025;15:390.
    PubMed    
    Abstract available

  281. BONALA SR, Subramanian BV, Venati C, Raja SA, et al
    Long-Term Outcomes of Simultaneous Integrated Boost in Node-Positive Cervical Cancer: A Single-Institution Retrospective Study.
    Cureus. 2025;17:e94828.
    PubMed    
    Abstract available

  282. LI Z, Lin Z, Qin P, Xiao R, et al
    Construction of a Risk-Prediction Model for Severe Bone Marrow Suppression During Radiotherapy in Cervical Cancer Patients.
    Clin Med Insights Oncol. 2025;19:11795549251380662.
    PubMed    
    Abstract available


  283. Retraction: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
    Front Mol Biosci. 2025;12:1712893.
    PubMed    
    Abstract available

  284. SISODIYA S, Singh P, Joshi T, Aftab M, et al
    Human papillomavirus-mediated cervical cancer: epigenetic interplay and clinical implications.
    Front Microbiol. 2025;16:1633283.
    PubMed    
    Abstract available

  285. LI Q, Zhou Z, Li X, Lan Q, et al
    LncRNA-EME1 enhances BRCA1 recruitment and alters repair of DNA damage in cervical cancer radioresistance.
    Noncoding RNA Res. 2025;16:57-69.
    PubMed    
    Abstract available

  286. CHEN X, Zheng L, Zeng X, Pan N, et al
    The potential role of miR-155 in the tumorigenesis of cervical cancer.
    Front Cell Dev Biol. 2025;13:1572373.
    PubMed    
    Abstract available

  287. YAO D, Ding H, Wang W
    Efficacy and prognosis of concurrent chemoradiotherapy in the management of recurrent cervical cancer: a retrospective study.
    Am J Transl Res. 2025;17:7021-7029.
    PubMed    
    Abstract available

  288. BOATMAN D, Jarrett Z, Ashcraft AM, Haggerty T, et al
    Community co-design of research intervention materials to reduce cervical cancer disparities in Appalachia.
    PEC Innov. 2025;7:100434.
    PubMed    
    Abstract available

  289. SAYED NADY D, Abdel-Halim SA, Hegazy MF, Aljohani S, et al
    In Vitro antiproliferative potential of essential oil extract from Carica papaya L. seeds against cervical cancer.
    Front Pharmacol. 2025;16:1676006.
    PubMed    
    Abstract available

  290. JONES J
    Screening learning module: Huang et al (2025), association between screening history and prognosis of cervical carcinoma in situ and invasive cervical cancer - A population-based cohort study.
    Ann Epidemiol. 2025;109:143-144.
    PubMed    
    Abstract available

  291. WANG L, Li W, Zhu X, Zhao B, et al
    The role of bromodomain-containing protein 4 in the replication human papillomavirus, apoptosis, proliferation and migration of cervical cancer cells.
    Eur J Pharmacol. 2025 Oct 16:178261. doi: 10.1016/j.ejphar.2025.178261.
    PubMed    
    Abstract available

  292. HYATT A, Canfell K, Moodie R, Aranda S, et al
    Achieving cervical cancer elimination: an ecological assessment of global determinants using a policy determinant model.
    Lancet Glob Health. 2025;13:e1828-e1836.
    PubMed    
    Abstract available

  293. WANG Y, Li H, Tian S, Sun J, et al
    SLC5A6 Regulates Lipid Metabolism and Lymph Node Metastasis in Cervical Cancer via FASN.
    Mol Carcinog. 2025 Oct 18. doi: 10.1002/mc.70052.
    PubMed    
    Abstract available

  294. ZHU X, Li S, Zhuang C
    Prevalence characteristics of human papillomavirus among women in Henan Province of China.
    Virol J. 2025;22:332.
    PubMed    
    Abstract available

  295. VANDYCK-SEY PNEW, Burchett HED
    Efforts to increase uptake of cervical cancer screening in the absence of a national programme in Ghana: a qualitative study of stakeholders' experience.
    BMC Public Health. 2025;25:3530.
    PubMed    
    Abstract available

  296. ZHUOYAO L, Xiaohan W, Xinyu M, Songling Z, et al
    The co-regulation of HPV infection by vaginal microbiota and the immune system.
    Virol J. 2025;22:334.
    PubMed    
    Abstract available

  297. JOHN A, Abbah AP, Sandoy IF
    Associations of socioeconomic factors with parents' awareness and acceptability of HPV vaccination in sub-Saharan Africa - a systematic review and meta-analysis.
    BMC Public Health. 2025;25:3525.
    PubMed    
    Abstract available

  298. DALVI SD, Ratnaparkhi MP, Badhe RN, Matkar BS, et al
    Targeted drug delivery in cervical carcinoma: the role of gold nanoparticles in enhancing treatment efficacy.
    Med Oncol. 2025;42:522.
    PubMed    
    Abstract available

  299. LI C, Zhu Y, Li N, Dai B, et al
    Topical vaginal drug therapy in cervical cancer management: a review of clinical trials and preclinical evidence.
    Med Oncol. 2025;42:523.
    PubMed    
    Abstract available

  300. LI S, Li H, Li Y, Cui Y, et al
    miR-378, miR-20a, and miR-520a-3p can be used in a novel serum prognostic panel for cervical cancer.
    Sci Rep. 2025;15:36410.
    PubMed    
    Abstract available

  301. KIM H, Deng W, Zamarin D, Xiao Y, et al
    Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer.
    Brachytherapy. 2025 Oct 16:S1538-4721(25)00312.
    PubMed    
    Abstract available

  302. JIA L, Cui X, Li X, Li R, et al
    Integrative multi-omics analysis identifies mitochondria- and ferroptosis-related prognostic genes in cervical cancer.
    Exp Cell Res. 2025 Oct 15:114796. doi: 10.1016/j.yexcr.2025.114796.
    PubMed    
    Abstract available

  303. AMANI A, Bloem P, Kobayashi E, Atuhaire B, et al
    Scaling HPV vaccination in Africa to eliminate cervical cancer by 2030.
    Lancet Glob Health. 2025 Oct 14:S2214-109X(25)00349.
    PubMed    


  304. MA Y, Lin S, Chen Q, Xue J, et al
    Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study.
    Cell Rep Med. 2025;6:102396.
    PubMed    
    Abstract available

  305. CAO X, Borah P, Lee DKL, Vishnevskaya A, et al
    Beyond the post: The impact of politized anti-vaccine misinformation comments and challenges of correction on social media.
    Vaccine. 2025;65:127760.
    PubMed    
    Abstract available

  306. SCOTT H, Kamraoui I, White MPJ, Davis C, et al
    Reference gene evaluation for digital PCR; Applications for RNA biomarker testing in cervical precancer.
    J Virol Methods. 2026;339:115268.
    PubMed    
    Abstract available

  307. FAN P, Dong D, Feng Y, Zhu X, et al
    Single-cell analysis identifies PI3+S100A7+keratinocytes in early cervical squamous cell carcinoma with HPV infection.
    Chin Med J (Engl). 2025;138:2615-2630.
    PubMed    
    Abstract available

  308. LEMOINE L, Adam V, Salleron J, Cuisinier C, et al
    Randomized trial comparing hypnosis versus standard management on patient anxiety and pain during pelvic brachytherapy applicator removal.
    Brachytherapy. 2025;24:854-862.
    PubMed    
    Abstract available

  309. RAJAN SS, Ning MS, Jacobson M, Simiele SJ, et al
    Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers.
    Brachytherapy. 2025;24:844-853.
    PubMed    
    Abstract available

  310. GRACIA SAENZ L, Shalygina S, Roca R, Ortuno S, et al
    Identification of germline mutations in DICER1 through routine somatic NGS analysis in various neoplasms.
    Rev Esp Patol. 2025;58:100834.
    PubMed    
    Abstract available

  311. KURITA Y, Meguro S, Sugiura Y, Togo S, et al
    Whole Slide Imaging-Free Supporting Tool for Cytotechnologists in Cervical Cytology.
    Mod Pathol. 2025;38:100817.
    PubMed    
    Abstract available

  312. KIR G, Erbagci A, Ozen F, Sayit D, et al
    HPV-independent squamous sell carcinoma of cervix: a clinicopathological, immunohistochemical, and molecular analysis of six cases.
    Virchows Arch. 2025;487:775-786.
    PubMed    
    Abstract available

  313. BAENA A, Picconi MA, Mendoza L, Ferrera A, et al
    Short-term repeat HPV testing for triaging HPV-positive women in cervical cancer screening.
    Br J Cancer. 2025 Oct 3. doi: 10.1038/s41416-025-03193.
    PubMed    
    Abstract available

  314. THAKUR S, Suteri P, Sharma DN, Mathur S, et al
    A Sneak Peek Into a Rare Case of Metastatic Cervix Adenocarcinoma in Pleural Fluid With an Approach to Diagnosis.
    Cytopathology. 2025;36:619-622.
    PubMed    
    Abstract available

  315. TOYODA S, Morita K, Ito F, Niiro E, et al
    Large Cell Neuroendocrine Carcinoma of the Uterine Cervix With a Biphasic Synaptophysin Staining Pattern and Followed Vaginal Intraepithelial Recurrence: A Case Report.
    Cytopathology. 2025;36:602-605.
    PubMed    
    Abstract available

  316. GIACHINI C, Pompeo G, Puliti D, Gorini G, et al
    From the Daily Peer Review of Abnormal Pap Test Slides to the Monitoring of Individual and Laboratory Performances: 5 Years of Data Collection and New Potential (Key) Performance Indicators.
    Cytopathology. 2025;36:558-567.
    PubMed    
    Abstract available

  317. KINKOROVA LUNACKOVA I, Ondic O, Nemcova J, Cerna K, et al
    The Methylation Test Is Highly Sensitive for HPV-Associated Endocervical Adenocarcinoma and Could Be Helpful as a Cytological Ancillary Test in Women With a PAP-Smear Diagnosis of Severe Glandular Lesion (AGC-NEO+).
    Cytopathology. 2025;36:568-571.
    PubMed    
    Abstract available

  318. SOOD N, Gupta R, Gupta S
    Villoglandular Carcinoma of the Uterine Cervix: Clinic-Cytopathological-Histological Features of a Rare Case With Brief Review of the Literature.
    Cytopathology. 2025;36:596-601.
    PubMed    
    Abstract available

  319. TANAKA K, Lami K, Odate T, Hori T, et al
    Cytology Screening Using Z-Stack Digital Slides: A Validation Study.
    Diagn Cytopathol. 2025;53:568-575.
    PubMed    
    Abstract available

  320. ZHOU Q, Luo K, Zhao L
    A Study on the Impact of HPV Genotype Infection Patterns on the Occurrence of High-Grade Squamous Intraepithelial Lesion.
    Diagn Cytopathol. 2025;53:529-535.
    PubMed    
    Abstract available

  321. BRUN JL, Bergeron C, Averous G, Ardaens K, et al
    Management of women with abnormal cervical cytology: Update of French guidelines after the implementation of HPV screening.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114661.
    PubMed    
    Abstract available

  322. MCKEOWN C, Kumar P, Cheung M, Marchocki Z, et al
    Beyond the transformation zone: Outcomes in the management of CGIN over five years.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114712.
    PubMed    
    Abstract available

  323. ZHAO Q, Lv S, Liu F
    Combined therapy for LSIL with HR-HPV: CO(2) laser and interferon alpha2a.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114686.
    PubMed    
    Abstract available

  324. XU X, Cruickshank ME, Woolner AMF
    The impact of human papillomavirus (HPV) vaccination on the risk of adverse obstetric outcomes: a data linkage study.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114678.
    PubMed    
    Abstract available

  325. KOCIAN R, Kohler C, Klat J, Jarkovsky J, et al
    Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study.
    Gynecol Oncol. 2025;202:118-124.
    PubMed    
    Abstract available

  326. CHASE DM, Huang HQ, Deng W, Koh WJ, et al
    Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-026
    Gynecol Oncol. 2025;202:102-109.
    PubMed    
    Abstract available

  327. ZHONG F, Ren Z, Li W, Jones T, et al
    The sensitivity and specificity of Claudin18.2 and MUC6 in the differential diagnosis of endocervical gastric-type glandular lesions.
    Hum Pathol. 2025;160:105837.
    PubMed    
    Abstract available

  328. CHINULA L, Chagomerana MB, Mkochi T, Msowoya L, et al
    Single visit screen-triage-treat strategy using GeneXpert-based HPV testing of self-collected cervicovaginal samples and thermal ablation treatment for cervical cancer prevention among women in Lilongwe, Malawi.
    Int J Cancer. 2025 Oct 16. doi: 10.1002/ijc.70177.
    PubMed    
    Abstract available

  329. YU X, Nzoutchoum OL, Gao D, Hsu CD, et al
    Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.
    Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70193.
    PubMed    
    Abstract available

  330. SINGLA A, Mehta S, Grover A, Mishra AK, et al
    Cervical cancer screening: Is self-sampling the answer?
    Int J Gynaecol Obstet. 2025 Sep 30. doi: 10.1002/ijgo.70562.
    PubMed    
    Abstract available

  331. URBANO FP, Cury GR, Dos Santos CR, da Silva DJC, et al
    Introduction of DNA-HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget.
    Int J Gynaecol Obstet. 2025 Oct 14. doi: 10.1002/ijgo.70594.
    PubMed    
    Abstract available

  332. MURAD V, Chawla T, Brien CO
    The missing link in SHAPE: standardizing magnetic resonance imaging assessment of stromal invasion for cervical cancer.
    Int J Gynecol Cancer. 2025;35:102133.
    PubMed    


  333. DIAZ ES, Levin G, Aristizabal B, Fernandes A, et al
    Silicon dioxide, sodium selenite and citric acid vaginal gel, HPV infection, and cervical preinvasive disease: a narrative review.
    Int J Gynecol Cancer. 2025;35:102021.
    PubMed    
    Abstract available

  334. MATSUO K, Matsuzaki S, Nagase Y, Keymeulen S, et al
    Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2025;35:102674.
    PubMed    
    Abstract available

  335. FALLAH PN, Bowman P, Tran C, Chen V, et al
    Implementation of Human Papillomavirus Self-Collection and Barriers to Follow-Up Among Unhoused Individuals in Texas: The EMPOWER Study.
    Obstet Gynecol. 2025;146:710-717.
    PubMed    
    Abstract available

  336. ROSSI L, Nout R, Heijmen B
    Response to letter to editor "Re-evaluating 'Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy': The silent cumulative CTVIR deficit".
    Radiother Oncol. 2025 Oct 21:111217. doi: 10.1016/j.radonc.2025.111217.
    PubMed    


  337. FANG S, Gao M
    Re-evaluating 'Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy': The silent cumulative CTVIR deficit.
    Radiother Oncol. 2025 Oct 19:111216. doi: 10.1016/j.radonc.2025.111216.
    PubMed    


  338. SONG Y, Qin H, Huang S, Wang J, et al
    alpha-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis.
    BMC Cancer. 2025;25:1503.
    PubMed    
    Abstract available

  339. LI X, Mao Z, Li Q, He M, et al
    Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective study.
    BMC Cancer. 2025;25:1498.
    PubMed    
    Abstract available

  340. BRUNO MT, Cavallaro AG, Sudano MC, Fratto MC, et al
    Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.
    BMC Cancer. 2025;25:1486.
    PubMed    
    Abstract available

  341. WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
    Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
    BMC Cancer. 2025;25:1469.
    PubMed    
    Abstract available

  342. KONG L, Xiao X, Wan R, Zhao S, et al
    Immediate risk and 5-year cumulative risk of high-grade cervical lesions in high-risk HPV-positive patients with minor cytological abnormalities: a retrospective single-center study in China.
    BMC Cancer. 2025;25:1541.
    PubMed    
    Abstract available

  343. LAI R, Tan Q, Ding C, Xu Y, et al
    Habitat-based transformer model in pretreatment (18)F-FDG PET imaging for predicting prognosis in cervical cancer: a two-center retrospective study.
    BMC Cancer. 2025;25:1515.
    PubMed    
    Abstract available

  344. ZHU J, Zhou Q, Chen L, He Z, et al
    Predicting hematologic toxicity in advanced cervical cancer patients using interpretable machine learning models based on radiomics and dosimetrics.
    BMC Cancer. 2025;25:1516.
    PubMed    
    Abstract available

  345. JIANG P, Wei S, Li C, Qu A, et al
    Safety and efficacy of toripalimab plus concurrent chemoradiotherapy for locally advanced cervical cancer: a single-arm, phase Ib trial.
    BMC Cancer. 2025;25:1566.
    PubMed    
    Abstract available

  346. TESFOM HN, Gizaw M, Yilam M, Klein JMA, et al
    Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia.
    BMC Cancer. 2025;25:1557.
    PubMed    
    Abstract available

  347. SETSOAFIA EA, Sarfo-Annan G, Daniels J, Addae J, et al
    Experiences of patients with cervical cancer undergoing concurrent chemoradiation therapy at the Korle-Bu teaching hospital in Ghana: an explorative qualitative study.
    BMC Cancer. 2025;25:1547.
    PubMed    
    Abstract available

  348. MURENZI G, Kanyabwisha F, Demarco M, Muhoza B, et al
    Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus.
    PLoS One. 2025;20:e0333077.
    PubMed    
    Abstract available

  349. KAMAU SW, Jepkorir M, Kipkoech G, Lagu IJL, et al
    Antiproliferative activity of Grewia villosa ethyl acetate extract on cervical cancer HeLa cell line: Mechanistic insights through network pharmacology and functional assays approach.
    PLoS One. 2025;20:e0331649.
    PubMed    
    Abstract available

  350. ADISU MA, Habtie TE, Kitaw TA, Gessesse AD, et al
    The rising burden of female cancer in Ethiopia (2000-2021) and projections to 2040: Insights from the global burden of disease study.
    PLoS One. 2025;20:e0333787.
    PubMed    
    Abstract available

  351. ZHANG Z, Li Y, Huang H, Wei T, et al
    Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
    PLoS One. 2025;20:e0334128.
    PubMed    
    Abstract available

  352. CHOU HH, Chu PY, Wu YH, Feng C, et al
    Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
    PLoS One. 2025;20:e0333757.
    PubMed    
    Abstract available

  353. LARSSON GL, Carlsson J, Helenius G, Bergengren L, et al
    Molecular triage on HPV-positive samples in a cervical screening setting.
    PLoS One. 2025;20:e0333539.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;